3D Signatures Inc. and their proprietary platform technology set to manage the treatment of various diseases including Hodgkin’s Lymphoma.
A personalized medicine company with proprietary software that can analyze a patient’s chromosomal arrangement or signature, through a simple non-invasive blood test or tissue sample.
Measuring disease stage and genomic stability, as well as drug efficacy and potential side effects.
Unlike most diagnostic companies, the proprietary imaging software goes beyond identifying whether a patient suffers from a specific disease or condition.
Otherwise the analytics platform tells doctors how to personalize treatment and best manage the disease for each individual patient.
For more information on 3D Signatures (DXD.TO) please fill out the form below.